Lifespot Health (ASX: LSH) is striving towards its medical cannabis inhaler device program, which it claims will “significantly evolve the treatment options for patients both in Australia and overseas.” The firm is seeking to be a leader in the market, and is developing a solid clinical trial program which it aims to launch next year. … Continue reading Australian Firm to Start Trials of Medical Cannabis Vape Pen by 2021